International Business News - Health http://www.ibtimes.com/rss/feed/health.rss All articles are copyrighted by IBTimes.com 120 30 http://www.ibtimes.com/rss/feed/health.rss http://www.ibtimes.com/images/top_logo_ibt2_3.gif Smith & Nephew beat forecasts for the third quarter as patients and governments began to resume spending on surgical procedures after cutting back during the recession. http://www.ibtimes.com/articles/20091106/smith-nephew-q3-beats-hopes-sees-mkt-stabilising.htm http://www.ibtimes.com/articles/20091106/smith-nephew-q3-beats-hopes-sees-mkt-stabilising.htm Fri, 06 Nov 2009 04:12:23 EST Private equity firm TPG and the Canada Pension Plan struck on Thursday the biggest leveraged buyout deal of this year, worth $4 billion, to buy prescription drug sales data provider IMS Health Inc. http://www.ibtimes.com/articles/20091105/ims-agrees-tobln-deal-biggest-lbo.htm http://www.ibtimes.com/articles/20091105/ims-agrees-tobln-deal-biggest-lbo.htm Thu, 05 Nov 2009 13:41:26 EST CareFusion Corp, the medical device company spun off from Cardinal Health on Sept. 1, posted a higher-than-expected quarterly profit, driven by strong demand in ventilators for flu and emergency preparedness related to H1N1, or swine flu. http://www.ibtimes.com/articles/20091105/carefusion-beats-street-raises-outlook-shrs-jump.htm http://www.ibtimes.com/articles/20091105/carefusion-beats-street-raises-outlook-shrs-jump.htm Thu, 05 Nov 2009 10:59:15 EST TPG and the Canada Pension Plan on Thursday announced a deal to buy IMS Health Inc hich provides prescription drug sales data, for around $4 billion. http://www.ibtimes.com/articles/20091105/tpg-canada-pension-agree-tobln-ims-buyout.htm http://www.ibtimes.com/articles/20091105/tpg-canada-pension-agree-tobln-ims-buyout.htm Thu, 05 Nov 2009 10:53:11 EST Watson Pharmaceuticals Inc posted lower net income on Wednesday, as the generic drugmaker added spending to launch two brand-name medicines and saw lower revenue from its distribution unit. http://www.ibtimes.com/articles/20091104/watson-pharma-third-quarter-net-profit-falls.htm http://www.ibtimes.com/articles/20091104/watson-pharma-third-quarter-net-profit-falls.htm Wed, 04 Nov 2009 10:57:28 EST Aviv REIT Inc, a real estate investment trust that focuses on healthcare properties, postponed its initial public offering, which had been scheduled to price on Tuesday, according to one of the company's underwriters. http://www.ibtimes.com/articles/20091104/aviv-reit-ipo-postponed.htm http://www.ibtimes.com/articles/20091104/aviv-reit-ipo-postponed.htm Wed, 04 Nov 2009 10:52:53 EST Merck & Co and Schering-Plough Corp said their $41.1 billion merger will be completed later on Tuesday, marking the close of the second huge deal in the pharmaceutical industry in recent weeks. http://www.ibtimes.com/articles/20091104/merck-schering-plough-set-complete-merger.htm http://www.ibtimes.com/data/articleimgs/223440-merck-schering-plough-set-to-complete-merger.jpg http://www.ibtimes.com/articles/20091104/merck-schering-plough-set-complete-merger.htm http://www.ibtimes.com/articles/20091104/merck-schering-plough-set-complete-merger.htm Wed, 04 Nov 2009 10:38:50 EST Human Genome Sciences Inc said its experimental lupus drug Benlysta was successful in a late-stage clinical trial, paving the way for approval of the first new treatment for the disease in 50 years. http://www.ibtimes.com/articles/20091102/human-genome-glaxo-lupus-drug-works-in-2nd-trial.htm http://www.ibtimes.com/articles/20091102/human-genome-glaxo-lupus-drug-works-in-2nd-trial.htm Mon, 02 Nov 2009 12:08:01 EST Valeant Pharmaceuticals International posted a better-than-expected quarterly profit, helped by higher revenue from its specialty pharmaceutical segment, and raised its 2009 earnings view. http://www.ibtimes.com/articles/20091102/valeant-q3-beats-estimates-raises-09-profit-view.htm http://www.ibtimes.com/articles/20091102/valeant-q3-beats-estimates-raises-09-profit-view.htm Mon, 02 Nov 2009 10:11:02 EST Hospital products and generic drugmaker Hospira Inc on Tuesday said quarterly net earnings rose 42 percent, fueled by a new product launch, and it raised its full-year profit forecast. http://www.ibtimes.com/articles/20091027/hospira-q3-tops-estimates-boosts-outlook.htm http://www.ibtimes.com/articles/20091027/hospira-q3-tops-estimates-boosts-outlook.htm Tue, 27 Oct 2009 10:57:57 EDT U.S. drugmaker Merck & Co Inc's $41.1 billion takeover of smaller rival Schering-Plough Corp won approval from European Union antitrust regulators on Friday. http://www.ibtimes.com/articles/20091023/merck-takeover-schering-plough-wins-eu-approval.htm http://www.ibtimes.com/data/articleimgs/222889-merck-takeover-of-schering-plough-wins-eu-approval.jpg http://www.ibtimes.com/articles/20091023/merck-takeover-schering-plough-wins-eu-approval.htm http://www.ibtimes.com/articles/20091023/merck-takeover-schering-plough-wins-eu-approval.htm Fri, 23 Oct 2009 11:05:36 EDT Shares of AGA Medical Holdings Inc, a maker of devices for heart defects and blood vessel diseases, edged up 1 percent in their debut on Nasdaq Wednesday after the company's IPO priced below range. http://www.ibtimes.com/articles/20091021/aga-medical-uppct-nasdaq-debut.htm http://www.ibtimes.com/articles/20091021/aga-medical-uppct-nasdaq-debut.htm Wed, 21 Oct 2009 11:38:17 EDT Eli Lilly and Co posted third-quarter profit well above Wall Street expectations on Wednesday on strong performance of its major prescription drugs and lower taxes, sending shares up 1.9 percent. http://www.ibtimes.com/articles/20091021/lilly-profit-tops-estimates-on-drug-sales-taxes.htm http://www.ibtimes.com/articles/20091021/lilly-profit-tops-estimates-on-drug-sales-taxes.htm Wed, 21 Oct 2009 09:08:02 EDT Pfizer Inc reported higher third-quarter profit as aggressive cost-cutting offset a negative foreign exchange impact and declining sales of drugs, including those facing competition from cheaper generics. http://www.ibtimes.com/articles/20091020/pfizer-third-quarter-profit-rises.htm http://www.ibtimes.com/data/articleimgs/222628-view-of-belgian-headquarters-of-us-pharmaceutical.jpg http://www.ibtimes.com/articles/20091020/pfizer-third-quarter-profit-rises.htm http://www.ibtimes.com/articles/20091020/pfizer-third-quarter-profit-rises.htm Tue, 20 Oct 2009 13:48:01 EDT Biogen Idec Inc reported third-quarter earnings on Tuesday that topped expectations, but data related to its controversial multiple sclerosis drug was mixed and its shares fell 1.5 percent. http://www.ibtimes.com/articles/20091020/biogen-3rd-qtr-profit-beats-tysabri-data-mixed.htm http://www.ibtimes.com/articles/20091020/biogen-3rd-qtr-profit-beats-tysabri-data-mixed.htm Tue, 20 Oct 2009 11:13:25 EDT Vaccination programs against H1N1 swine flu are under way in the United States, China and Australia and will begin soon in parts of Europe. http://www.ibtimes.com/articles/20091008/qhow-do-you-know-you-have-flu.htm http://www.ibtimes.com/articles/20091008/qhow-do-you-know-you-have-flu.htm Thu, 08 Oct 2009 11:02:52 EDT Hype about the swine flu vaccines, pent-up demand for cash and a push by major drugmakers to boost their flagging research pipelines has helped lift biotechnology fund-raising 36 percent so far this year. http://www.ibtimes.com/articles/20091007/biotech-fundraising-amid-vaccine-hype-cash-need.htm http://www.ibtimes.com/articles/20091007/biotech-fundraising-amid-vaccine-hype-cash-need.htm Wed, 07 Oct 2009 18:53:36 EDT Western drugmakers are stepping up the hunt for emerging market "tigers" in India. http://www.ibtimes.com/articles/20091007/glaxo-eyes-dr-reddys-as-big-pharma-hunts-india.htm http://www.ibtimes.com/articles/20091007/glaxo-eyes-dr-reddys-as-big-pharma-hunts-india.htm Wed, 07 Oct 2009 11:04:04 EDT Merck KGaA is sticking to its initial target to make more than 1 billion euros ($1.45 billion) in sales from its Erbitux cancer drug as early as 2011, its chief executive told a German weekly. http://www.ibtimes.com/articles/20091002/merck-kgaa-quashes-erbitux-sales-doubts-magazine.htm http://www.ibtimes.com/articles/20091002/merck-kgaa-quashes-erbitux-sales-doubts-magazine.htm Fri, 02 Oct 2009 10:58:16 EDT German industrial heir Ludwig Merckle is more confident he may not need to sell drugs distributor Phoenix after cashing in shares in HeidelbergCement, two people familiar with his plans told Reuters. http://www.ibtimes.com/articles/20091002/merckle-more-optimistic-on-keeping-phoenix-sources.htm http://www.ibtimes.com/articles/20091002/merckle-more-optimistic-on-keeping-phoenix-sources.htm Fri, 02 Oct 2009 10:46:17 EDT